Janssen Search
Search results
Our Products
Article Type: Oncology Our Products We have a uniquely broad perspective and the ability to leverage our affiliates’ expertise throughout the cancer journey from prevention, diagnosis and treatment to the return to wellness. As part of the Johnson & ...
Michelle Wang Goodridge
Michelle Wang Goodridge is the Global Commercial Strategy Leader for Infectious Diseases & Vaccines (ID&V). Michelle is responsible for building and maximizing the value of the ID&V pipeline and marketed assets. She joined Johnson & ...
Focus: Thrombosis
Cardiology & Metabolism Focus: Thrombosis Cardiovascular disease is the leading cause of death worldwide. There is a tremendous need for effective anticoagulants. We currently have novel oral anticoagulant for patients in the United States. We are ...
Amy Han
AMY HAN ONCOLOGY COMMERCIAL DISEASE AREA LEADER SOLID TUMOR TARGETED THERAPIES As Oncology Commercial Disease Area Leader, Solid Tumor Targeted Therapies, Amy is the global oncology strategic leader responsible for the commercial optimization of the solid ...
Jennifer L. Taubert
JENNIFER L. TAUBERT EXECUTIVE VICE PRESIDENT WORLDWIDE CHAIRMAN, INNOVATIVE MEDICINE JOHNSON & JOHNSON Jennifer L. Taubert is Executive Vice President and Worldwide Chairman, Innovative Medicine at Johnson & Johnson, the world’s largest healthcare ...
Hepatitis B
Hepatitis B We are committed to easing the burden faced by the many millions of people living with chronic hepatitis B. There are nearly 300 million people chronically infected with hepatitis B today. Fewer than 20% of patients know they have the disease, ...
JCI Initiatives
JCI Initiatives Sep 02, 2020 Subhead: Lorem ipsum dolor sit amet, consectetuer adipiscing elit By combining the agility of a lean team, the resources and industry-leading position of Janssen, and the expertise and reach of innovative collaborators, JCI ...
Global Public Health
Global Public Health Global Public Health Nelly Velez, The World Among Us About Our Global Public Health Initiative Global Public Health Research Increasing Sustainable Access to Medicines Our Partnerships Fighting Multi-Drug Resistant Tuberculosis ...
Recognizing World Psoriasis Day
Recognizing World Psoriasis Day On October 29, World Psoriasis Day, we at Janssen recognize the debilitating effects diseases like psoriasis and psoriatic arthritis have on patients and their loved ones. That’s why, for more than a decade, our team has ...
Immune Therapy
Immune Therapy “Interventions that harness the power of the immune system have shown exciting potential in the treatment of cancer.” Joseph Erhardt, Ph.D. Vice President, Oncology Scientific Partnership Strategy One of the most significant advancements in ...